Scientists uncover neural pathway responsible for opioid withdrawal

February 4, 2016 by Rosemary Mena-Werth
New research by Stanford biologists holds the promise to develop a more effective treatment for drug addiction by suppressing the urges at their origin within the brain. Credit: Sergey Nivens/Shutterstock

In addition to the desire to experience a "high," one of the obstacles drug addicts encounter is the difficulty of overcoming a myriad of harsh withdrawal symptoms including anxiety, depression, nausea, vomiting and diarrhea. When people learn to associate the loss of drug use with the pain of withdrawal, it can create an urge to use that is as strong as the "high" itself, making it even more difficult to quit.

Some of these symptoms can be partially managed, but new research by Stanford biologists holds the promise to develop a more effective treatment for addiction by suppressing the urges at their origin within the brain.

A recent discovery by Stanford scientists has both pinpointed and controlled nerve centers in the brain that react to this aversive withdrawal stimuli. In this study, scientists were able to eliminate negative reactions to opiate in morphine-dependent mice.

"Most research that studies drug addiction is focused on the reward pathway because that is the reason you start to take drugs, but people who really get addicted also take drugs to get rid of the withdrawal effect. This is especially important in opiate addiction," said lead investigator Xiaoke Chen, an assistant professor of biology at Stanford.

The research, published in the current issue of Nature, began by studying the , a group of neurons in the brain that is commonly associated with drug reward. Other studies, however, have also shown that it responds to aversive stimuli, including drug withdrawal.

To further investigate this behavior, Chen and his colleagues used fluorescent proteins to illuminate brain centers and view the pathways that connect them. The experiment highlighted a particularly clear link between the nucleus accumbens and a small group of cells in the paraventricular nucleus of the thalamus (PVT).

The scientists then tested the link between the nucleus accumbens and the PVT using the technique of optogenetics developed at Stanford by Karl Deisseroth, the D. H. Chen Professor of bioengineering and of psychiatry and behavioral sciences. Optogenetics makes use of light-sensitive molecules that can convert photons into electric signals; the same process that occurs in the human eye. These molecules are introduced into a specific nucleus of the brain and can be used to turn neurons on or off via light from an optical fiber, thereby allowing specific manual control of neural activity.

Results of this testing showed the pathway to activate aversive reactions to drug withdrawal rather than reward. Chronic drug use strengthens the PVT-to-nucleus-accumbens pathway, Chen said, and this strengthening might be responsible for the heightened withdrawal responses that accompany addiction. Using optogenetic tools, the scientists were then able to revert the pathway to its original synaptic strength, effectively erasing the effects of the drug. Although the research was conducted in mice, Chen said it suggests that reprogramming this circuit holds promise for treating opiate addiction in humans.

"This is a knowledge-guided treatment. We not only identified a new pathway, but we actually established the causality between the plasticic change in this single synapse and opioid withdrawal symptoms," he said. "Drugs affect many places throughout the brain, but here we manipulate this single synapse and can get rid of this drug effect."

The PVT-to-nucleus-accumbens pathway is also responsible for controlling behavioral response to nondrug aversive stimuli. In the future, Chen hopes that his research will lead to safer, guided treatments for drug addictions and other, nondrug related behaviors. Exaggerated aversive response to external stimulation is a common phenomenon for many people dealing with anxiety and depression.

"That's one of the reasons they try to avoid social interaction," Chen said. "They don't want to get hurt. But I am hopeful that this work will provide scientists with the insight to help people overcome these afflictions."

Explore further: Nicotine withdrawal traced to very specific group of brain cells

More information: Yingjie Zhu et al. A thalamic input to the nucleus accumbens mediates opiate dependence, Nature (2016). DOI: 10.1038/nature16954

Related Stories

Nicotine withdrawal traced to very specific group of brain cells

November 14, 2013
Nicotine withdrawal might take over your body, but it doesn't take over your brain. The symptoms of nicotine withdrawal are driven by a very specific group of neurons within a very specific brain region, according to a report ...

Scientists discover a novel opiate addiction switch in the brain

September 10, 2013
Neuroscientists at Western University (London, Canada) have made a remarkable new discovery revealing the underlying molecular process by which opiate addiction develops in the brain. Opiate addiction is largely controlled ...

Reward, aversion behaviors activated through same brain pathways

September 2, 2015
New research may help explain why drug treatments for addiction and depression don't work for some patients.

Investigating the pleasure centers of the brain: How reward signals are transmitted

May 27, 2014
New research presented today by Dr. Jonathan Britt, from McGill University, helps to better understand how reward signals, such as those produced by addictive drugs, travel through the brain and modify brain circuits. Dr. ...

Researchers confirm important brain reward pathway

November 12, 2014
Details of the role of glutamate, the brain's excitatory chemical, in a drug reward pathway have been identified for the first time.

Scientists discover 'back door' into the brain that circumvents self-control in addicts

January 12, 2016
Individuals addicted to cocaine may have difficulty in controlling their addiction because of a previously-unknown 'back door' into the brain, circumventing their self-control, suggests a new study led by the University of ...

Recommended for you

'Residual echo' of ancient humans in scans may hold clues to mental disorders

July 26, 2017
Researchers at the National Institute of Mental Health (NIMH) have produced the first direct evidence that parts of our brains implicated in mental disorders may be shaped by a "residual echo" from our ancient past. The more ...

Laser used to reawaken lost memories in mice with Alzheimer's disease

July 26, 2017
(Medical Xpress)—A team of researchers at Columbia University has found that applying a laser to the part of a mouse brain used for memory storage caused the mice to recall memories lost due to a mouse version of Alzheimer's ...

Cognitive cross-training enhances learning, study finds

July 25, 2017
Just as athletes cross-train to improve physical skills, those wanting to enhance cognitive skills can benefit from multiple ways of exercising the brain, according to a comprehensive new study from University of Illinois ...

Brain disease seen in most football players in large report

July 25, 2017
Research on 202 former football players found evidence of a brain disease linked to repeated head blows in nearly all of them, from athletes in the National Football League, college and even high school.

Zebrafish study reveals clues to healing spinal cord injuries

July 25, 2017
Fresh insights into how zebrafish repair their nerve connections could hold clues to new therapies for people with spinal cord injuries.

Lutein may counter cognitive aging, study finds

July 25, 2017
Spinach and kale are favorites of those looking to stay physically fit, but they also could keep consumers cognitively fit, according to a new study from University of Illinois researchers.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 04, 2016
Most research that studies drug addiction is focused on the reward pathway because that is the reason you start to take drugs, but people who really get addicted also take drugs to get rid of the withdrawal effect.

The withdrawal is typically the inverse of the reward (a rebound effect). If the drug made you feel less anxious and more relaxed, for instance, then the baseline (how you felt before taking the drug) drops down so you feel more anxious and agitated thus you require the drug ever more (tolerance and rebound effect).

Thus we can say that the drug takes away in the long term whatever it provided in the short term.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.